Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain

BACKGROUND: Intravenous (IV) ketamine is used for chronic neuropathic pain refractory to other treatments. Administration of such a medication requires high-cost services while the result is not always satisfactory with a significant percentage of failure. Success and failure are related to some fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gargori, Nezar M. B., Alahwal, Hazem, Vacheron, Charles-Herve, Alam, Farouq Mohammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435804/
https://www.ncbi.nlm.nih.gov/pubmed/37601528
http://dx.doi.org/10.4103/sja.sja_737_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435804/
https://www.ncbi.nlm.nih.gov/pubmed/37601528
http://dx.doi.org/10.4103/sja.sja_737_22

Ejemplares similares